Capricor Therapeutics Inc (CAPR) Q4 2025 Earnings Call Highlights: FDA Milestones and Financial ... [Yahoo! Finance]
Capricor Therapeutics, Inc. (CAPR)
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
capricor.com/investors
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Release Date: March 12, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Capricor Therapeutics Inc ( NASDAQ:CAPR ) received FDA acceptance for their Biologics License Application (BLA) for Jeremiasel, with a target action date set for August 22, 2026. The HOPE 3 trial showed significant results, meeting primary and secondary endpoints, indicating Jeremiasel's potential to stabilize both skeletal and cardiac muscle function in Duchenne muscular dystrophy patients. The company has a strong financial position with approximately $318 million in cash and marketable securities, sufficient to fund operations into the fourth quarter of 2027. Capricor Therapeutics Inc ( NASDAQ:CAPR ) successfully completed an FDA pre-license inspection of their manufacturing facility, positioning them well for potential commercial launch. The company is expanding its manufacturing c
Show less
Read more
Impact Snapshot
Event Time:
CAPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAPR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAPR alerts
High impacting Capricor Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CAPR
News
- Exosome Research Market Analysis, Opportunity Forecasts Report 2026-2035 [Yahoo! Finance]Yahoo! Finance
- Capricor signals potential commercialization of Deramiocel with $318M cash balance and FDA review milestone [Seeking Alpha]Seeking Alpha
- Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Capricor Therapeutics, Inc. GAAP EPS of -$0.62 misses by $0.08, revenue of $0M [Seeking Alpha]Seeking Alpha
- Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate UpdateGlobeNewswire
CAPR
Earnings
- 3/12/26 - Miss
CAPR
Sec Filings
- 3/12/26 - Form 8-K
- 3/10/26 - Form 8-K
- 2/26/26 - Form SCHEDULE
- CAPR's page on the SEC website